Microbot Medical Inc. announced on July 8, 2025, its participation in the inaugural Endovascular Robotics session at the Society of Robotic Surgery (SRS) annual meeting. The meeting is scheduled to be held from July 16-20 in Strasbourg, France.
Harel Gadot, the company’s Chairman, CEO, and President, will present an overview of the endovascular robotic market during the panel session titled 'Endovascular Robotics; the next frontier for robotic surgery.' He will be joined by representatives from other medical robotics companies.
This event provides Microbot Medical with a timely platform to introduce and educate interventional radiologists and the broader medical community on the LIBERTY system. The company is strengthening its sales and marketing infrastructure as part of its LIBERTY launch plans in the United States, while awaiting the anticipated FDA 510(k) decision during the current quarter.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.